Cormorant Asset Management, LP 13D and 13G filings for VYNE Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-11-13 4:03 pm Purchase | 2023-11-01 | 13G | VYNE Therapeutics Inc. VYNE | Cormorant Asset Management, LP | 1,394,336 9.990% | 1,394,336 (New Position) | Filing |